G Medical Innovations Holdings (G Medical Innovations Holdings) Interest Expense : $-4.08 Mil (TTM As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. G Medical Innovations Holdings's interest expense for the six months ended in Dec. 2022 was $ 0.33 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2022 was $-4.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. G Medical Innovations Holdings's Operating Income for the six months ended in Dec. 2022 was $ -6.62 Mil. G Medical Innovations Holdings's Interest Expense for the six months ended in Dec. 2022 was $ 0.33 Mil. G Medical Innovations Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

G Medical Innovations Holdings Interest Expense Historical Data

The historical data trend for G Medical Innovations Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Interest Expense Chart

G Medical Innovations Holdings Annual Data

Trend

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-1.00

-3.85

-0.75

-4.49

-4.08

G Medical Innovations Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Interest Expense	Get a 7-Day Free Trial							-0.19	-0.95	-3.54	-4.41	0.33

G Medical Innovations Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-4.08 Mil.

G Medical Innovations Holdings (OTCPK:GMVDF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

G Medical Innovations Holdings's Interest Expense for the six months ended in Dec. 2022 was $0.33 Mil. Its Operating Income for the six months ended in Dec. 2022 was $-6.62 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2022 was $0.28 Mil.

G Medical Innovations Holdings's Interest Coverage for the quarter that ended in Dec. 2022 is calculated as

The higher the ratio, the stronger the company's financial strength is.

G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Oppenheimer Street, Rehovot, ISR, 7670105

Website

https://www.gmedinnovations.com

G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

Executives

Awm Investment Company, Inc.

10 percent owner

527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022